INSIGHTS
Insights that cut through complexity
Menu
Unpacking the Biosimilar Buzz
As industry experts, it’s the number one topic we’re being asked to comment on. While biosimilars have existed for many…
Study Shows Talarozole May Help Osteoarthritis Patients
Healthline recently asked me to provide context for an article about recent research showing that talarozole may reduce and modify…
Competition is on the Horizon for Costly Narcolepsy Treatments
See this article by RemedyOne clinical pharmacist, Jason Peterson, R.Ph. as it originally appeared in Pharmaphorum. People who live with narcolepsy —…
It’s Been a Long Time Coming for Long-Term Topical Psoriasis Treatments
RemedyOne EVP of clinical services Robert Louie recently published an article for Pharmaphorum about topical psoriasis treatments Vtama and Zoryve.…
Relyvrio and the ALS Treatment Landscape
Amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig’s Disease, is a rare, progressive, neurodegenerative disorder that affects nerve…
Enhertu: The New Oncology ‘Smart Bomb’
An article on Health.com recently quoted me about an exciting new FDA-approved drug shown to extend metastatic breast cancer patients’…
Monkeypox
Recent months have brought new waves of viral infections across the globe, particularly, monkeypox. Scientists first identified monkeypox in Denmark…
Mounjaro: Competing To Be the Best
Jason Peterson and RemedyOne EVP of clinical services Robert Louie have also written about Mounjaro for Pharmaphorum. Man o’ War,…
Drug Treatment of Presbyopia: Medical Necessity or Convenience?
Some say things get better with age. Cheese, wine, and whiskey are a few examples that come to mind. Unfortunately,…
Six Months After Authorization, What Do We Know About Paxlovid?
See this article by RemedyOne EVP of clinical services Robert Louie as it originally appeared in Pharmaphorum. It has now…
How the Pharmaceutical Industry Can Turn the Tide on Mental Health
May is Mental Health Awareness Month. RemedyOne president Ralph Pisano wrote this article for Fierce Healthcare about how the pharmaceutical…
New Developments in Macular Degeneration/Diabetic Eye Disease
Visual impairment can be a major health issue for older adults, ranging from a minor inconvenience to vision loss significantly…
Drug Innovation Continues Despite a World-Wide Pandemic
While much of the world was on pause during the COVID-19 pandemic, there are definite signs that even a pandemic…
Three Pharmacy Trends That Will Define 2022
See article as it originally appeared in MedCity News. The pharmaceutical industry made more headlines in 2021 than in any…
2022 Q1 RemedyOne Quarterly Pipeline Report
Download our 2022 Q1 Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
High Cost, Lifelong Treatments and the Impact on Payers and Patients
Healthcare payers may not be familiar with the high costs of paroxysmal nocturnal hemoglobinuria (PNH), or even know what it…
Want the Lowest-Net-Cost Drugs? Change Your Thinking on Disruption
It might seem like a lowest-net-cost formulary would be made up of clinically equivalent agents with the lowest overall cost.…
COVID-19 Treatment Developments
Introduction Recent data from Johns Hopkins University showed over 760,000 people in the U.S. have died from the coronavirus to…
Q3 2021 Drug Pipeline Recap
The Latest Developments in Drug Approvals Each quarter, the RemedyOne Clinical team curates a drug pipeline report for our clients…
2021 Q4 RemedyOne Quarterly Pipeline Report
Download our 2021 Q4 Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
No One Really Knows How We’ll Pay for Gene Therapies
Gene therapies are here and they have the potential to be miraculous. And extremely expensive. The science behind these therapies…
COVID-19 Treatment Update
The last year and a half brought many rapid changes and innovations across the globe and in no area more than healthcare. From finding the most effective treatments to developing tests and…
The Implications of Polypharmacy on the Payor and Patient
There is a delicate balance between prescribing new medications and identifying and eliminating unnecessary prescriptions to protect the overall care…
2021 Q3 RemedyOne Quarterly Pipeline Report
Download our 2021 Q3 Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
Biogen’s New Alzheimer’s Drug is a Compound of Hope and Controversy
For the first time in 18 years, the FDA has approved a drug to treat patients with Alzheimer’s disease. It’s…
Can the Vaccine Rollout Guide Us to More Efficient Health Care?
What the Covid vaccine taught us, and how we can be better. See this article as it originally appeared in…
Effects of COVID-19 on Mental Health
As the number of COVID-19 hospitalizations and deaths are trending downward and vaccines are currently showing efficacy in the U.S.,…
Hospital Price Transparency Rule Not Enough to Lower Drug Prices
Our healthcare system is extremely complex and increasing drug pricing transparency will be a big part of simplifying it in…
2021 Q2 RemedyOne Quarterly Pipeline Report
Download our 2021 Q2 Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
Digital Health Trends: Digital Therapeutics
Defining the Digital Health Landscape Digital health has been a trending topic for several years now. Using technology to improve…
The Latest on HIV Treatment
History HIV treatment has come a long way since 1987 when the first breakthrough zidovudine, a failed cancer drug from…
The Most Favored Nation Model and Interim Final Rule – What is this?
The rising costs of physician-administered drugs covered under Medicare Part B is one of the largest drivers of Medicare spend…
“Alexa, Refill My Prescription!”
Introducing: Amazon Pharmacy….. What this launch means for the $300 billion prescription drug market and the traditional pharmacy chains currently…
Don’t Let the Fox Guard Your Henhouse: 6 Questions to Ask Your Large National Broker
Pharmacy benefits are complex, seemingly on purpose. If you are with a large national broker and are utilizing their coalition…
COVID-19 Vaccine Update
COVID-19 has infected over 10 million people in the United States and has claimed the lives of over 237,000 people…
Cutting Through the Complexity of Biosimilars
The biologic drug market is huge in the US and it continues to grow at a rapid pace. However, great…
Uncovering Solutions for Affordable Drug Pricing
The House Committee on Oversight and Reform held a series of hearings to review findings from an in-depth investigation into…
RemedyOne Drug Spotlight: Rukobia
Rukobia (fostemasavir) There are an estimated 2 million people living with the human immunodeficiency virus (HIV) in the United States.…
CMS’s Proposed Prescription Drug Value-Based Purchasing Rule
Paving the Way for Payment Innovation On June 17, 2020, CMS announced a proposed rule that would change how pharmaceutical manufacturers…
Arbuterol 101 Plus...
Albuterol is a short acting beta agonist (SABA) used to treat or prevent bronchospasm in patients with reversible obstructive airway…
Acute Migraine Treatments – What’s New?
Migraine is a neurological disorder with severe throbbing/pulsating headache generally associated with visual disturbances, nausea, vomiting, dizziness, and sensitivity to…
Gene Therapy – It’s Here, Are You Ready?
Thanks to advances in modern medicine, diseases caused by genetic disorders such as spinal muscular atrophy and retinal defects can…
Pandemic Response Update—Insights Into the Cycle
As the COVID-19 Pandemic continues to sweep across the US, it seems there are new updates on the healthcare front…
Navigating the Complex World of Generics and Authorized Generics
Executive Summary Today, generics are widely available and more regulated, with improved quality compared to that of the not-so-distant past.…
What’s Really Going on with Drug Prices?
Are prices up? Down? Staying the Same? The answer depends on who you listen to and when. In an atmosphere…
Like what you’re seeing?
Get more Insights sent to you.
